Introduction
This information will help you understand your choices, whether you share in the decision-making process or rely on your doctor's recommendation.
Key points in making your decision
If your benign prostatic hyperplasia (BPH) is causing lower urinary tract symptoms, options include watchful waiting, medicine, and surgery. Generally, watchful waiting or medicines are considered first, and then surgery. This Decision Point focuses on deciding between watchful waiting and medicines.
Consider the following when making your decision:
- If you have acute urinary retention (AUR, a blockage of the urethra that makes urination impossible) that comes back, urinary tract infections that happen again, kidney problems, bladder stones or bladder infections, or blood in your urine, watchful waiting or medicine is usually not an option. Talk to your doctor about surgery.
- The American Urological Association (AUA) symptom index is used to help men determine the severity of their urinary symptoms and can also be used to measure the effectiveness of treatment. But the most important factor in deciding whether to get treatment is not your AUA rating, but how much the symptoms bother you and affect your quality of life.
- Your BPH symptoms may come and go, stabilize, or get better over time. About 4 out of 10 men improve without treatment.1
- You may find the side effects of medicine more bothersome than your BPH symptoms.
- Medicines may decrease the risk for acute urinary retention and future surgery.2
Medical Information
What is benign prostatic hyperplasia?
Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland that occurs in almost all men as they age. The enlargement is usually harmless, but it often results in problems urinating. About half of all men older than 75 have some symptoms.3
What are the risks of BPH?
BPH can be inconvenient and may affect your quality of life, but it is usually not a serious problem.
In a small number of cases, BPH may cause bladder outlet obstruction (BOO), making it impossible or extremely difficult to urinate. This may result in backed-up urine (urinary retention), leading to bladder infections or stones or kidney damage.
BPH may also irritate the bladder muscles as they enlarge to compensate for the increased force needed to empty the bladder.
BPH does not cause prostate cancer and does not affect a man's ability to father children. And it doesn't usually result in erection problems. But there is some association between severe symptoms of BPH and an increased risk of erection problems.
If you need more information, see the topic Benign Prostatic Hyperplasia (BPH).
Your Information
Your choices are:
- Try watchful waiting. Manage your BPH through fluid intake and bathroom techniques, and see your doctor regularly to monitor your condition.
- Use herbal therapy to relieve your symptoms.
- Use prescription medicine to relieve your symptoms.
Options include:
- Alpha-blockers, such as alfuzosin (Uroxatral), doxazosin (Cardura), tamsulosin (Flomax), and terazosin (Hytrin), which relax muscle tissue.
- 5-alpha reductase inhibitors, such as dutasteride (Avodart) or finasteride (Proscar), which shrink the prostate.
The decision about whether to use medicines for BPH takes into account your personal feelings and the medical facts.
The American Urological Association (AUA) symptom index is used to help men determine the severity of their urinary symptoms and can also be used to measure the effectiveness of treatment. But the most important factor in deciding whether to get treatment is not your AUA rating, but how much the symptoms bother you and affect your quality of life.
| Reasons to use medicine | Reasons not to use a medicine but to practice watchful waiting |
|---|---|
Are there other reasons you might want to use medicines? |
Are there other reasons you might not want to use medicines? |
| Reasons to use 5-alpha reductase inhibitors | Reasons not to use 5-alpha reductase inhibitors |
|---|---|
Are there other reasons you might want to use 5-alpha reductase inhibitors? |
Are there other reasons you might not want to use 5-alpha reductase inhibitors? |
| Reasons to use alpha-blockers | Reasons not to use alpha-blockers |
|---|---|
Are there other reasons you might want to use alpha-blockers? |
Are there other reasons you might not want to use alpha-blockers? |
Using a combination of an alpha-blocker with a 5-alpha reductase inhibitor may help your symptoms more than either medicine alone.7, 8
These personal stories may help you make your decision.
Wise Health Decision
Use this worksheet to help you make your decision. After completing it, you should have a better idea of how you feel about using medicine for benign prostatic hyperplasia. Discuss the worksheet with your doctor.
Circle the answer that best applies to you.
| I have mild or moderate symptoms that don't really bother me. | Yes | No | Unsure |
| I have moderate or severe symptoms that bother me. | Yes | No | Unsure |
| I understand that my symptoms may come and go or get better or worse. | Yes | No | Unsure |
| I have a large prostate. | Yes | No | Unsure |
| I worry about the side effects of medicine. | Yes | No | Unsure |
| I have tried watchful waiting and/or herbal therapies, and my symptoms are the same. | Yes | No | NA* |
| I have recurrent urinary retention, recurrent urinary tract infections, kidney problems, bladder stones or infection, or urine in the blood. | Yes | No | NA |
*NA = Not applicable
Use the following space to list any other important concerns you have about this decision.
|
What is your overall impression?
Your answers in the above worksheet are meant to give you a general idea of where you stand on this decision. You may have one overriding reason to use or not use medicines for benign prostatic hyperplasia.
Check the box below that represents your overall impression about your decision.
Leaning toward watchful waiting | Leaning toward medicines |
Return to the topic Benign Prostatic Hyperplasia (BPH).
References
Citations
Roehrborn CG, McConnell JD (2007). Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In AJ Wein, ed., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 27272765. Philadelphia: Saunders Elsevier.
Webber R (2006). Benign prostatic hyperplasia, search date May 2005. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Presti JC, et al. (2008). Benign prostatic hyperplasia (BPH) section of Neoplasms of the prostate gland. In EA Tanagho, JW McAninch, eds., Smiths General Urology, 17th ed., pp. 348370. New York: McGraw-Hill.
Paterson R, Goldenberg L (2001). Benign prostatic hyperplasia. In J Teichman, ed., 20 Common Problems in Urology, part 2, pp. 185198. New York: McGraw-Hill.
Barry MJ (2007). Benign prostatic hyperplasia. In DC Dale, DD Federman, eds., ACP Medicine, section 10, chap. 13. New York: WebMD.
Kirby R, Lepor H (2007). Evaluation and nonsurgical management of benign prostatic hyperplasia. In AJ Wein, ed., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 27662802. Philadelphia: Saunders Elsevier.
McConnell JD, et al. (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine, 349(25): 23872398.
Roehrborn CG, et al. (2008). The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. Journal of Urology, 179(2): 616621.
Credits
| Author | Monica Rhodes |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Specialist Medical Reviewer | Christopher G. Wood, MD, FACS - Urology/Oncology |
| Last Updated | March 24, 2008 |
| Author: | Monica Rhodes | Last Updated: March 24, 2008 |
| Medical Review: | E. Gregory Thompson, MD - Internal Medicine Christopher G. Wood, MD, FACS - Urology/Oncology | |
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions. | ||


Seton is proud to have four hospitals – the only hospitals in Central Texas - that have earned the